Cresco Labs Inc. (CRLBF) Total Liabilities (2019 - 2026)

Cresco Labs (CRLBF) has reported Total Liabilities for 8 consecutive years, with $1000.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities rose 1.33% year-over-year to $1000.0 million; the trailing twelve-month figure through Jun 2026 stood at $1000.0 million (up 1.33% YoY), and the FY2025 full-year result was $944.8 million, down 2.31% from the prior year.
• Total Liabilities rose to $1000.0 million in Q2 2026 per CRLBF's latest filing, from $954.6 million in the prior quarter.
• Across five years, Total Liabilities topped out at $1.0 billion in Q1 2022 and bottomed at $917.4 million in Q2 2022.
• Historically, Total Liabilities has averaged $971.9 million across 5 years, with a median of $978.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 46.56% in 2022, then retreated 7.61% in 2025.
• Over 5 years, Total Liabilities stood at $996.0 million in 2022, then declined by 6.59% to $930.4 million in 2023, then rose by 3.95% to $967.2 million in 2024, then decreased by 2.31% to $944.8 million in 2025, then grew by 5.84% to $1000.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $1000.0 million, $954.6 million, and $944.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.